Sanofi, GSK can't escape Zantac proposed class actions, judge rules – Reuters

Sanofi, GSK can not get away Zantac recommended course activities, court guidelines – Reuters

Drugmakers consisting of Sanofi SA shed a quote to reject recommended course activities by customers that utilized the heartburn or purchased medication Zantac as well as are looking for reimbursements or clinical surveillance due to the fact that the medicine includes a possible carcinogen.Read More …